Annual Retained Earnings
-$2.20 B
+$226.45 M+9.32%
December 31, 2024
Summary
- As of March 10, 2025, ACAD annual retained earnings is -$2.20 billion, with the most recent change of +$226.45 million (+9.32%) on December 31, 2024.
- During the last 3 years, ACAD annual retained earnings has fallen by -$50.81 million (-2.36%).
- ACAD annual retained earnings is now -3961.64% below its all-time high of -$54.27 million, reached on December 31, 2002.
Performance
ACAD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$2.20 B
+$143.74 M+6.12%
December 31, 2024
Summary
- As of March 10, 2025, ACAD quarterly retained earnings is -$2.20 billion, with the most recent change of +$143.74 million (+6.12%) on December 31, 2024.
- Over the past year, ACAD quarterly retained earnings has stayed the same.
- ACAD quarterly retained earnings is now -3124.39% below its all-time high of -$68.37 million, reached on December 31, 2003.
Performance
ACAD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ACAD Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +9.3% | 0.0% |
| 3 y3 years | -2.4% | -2.4% |
| 5 y5 years | -29.4% | -29.4% |
ACAD Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.4% | +9.3% | -2.4% | +11.0% |
| 5 y | 5-year | -29.4% | +9.3% | -29.4% | +11.0% |
| alltime | all time | -3961.6% | +9.3% | -3124.4% | +11.0% |
ACADIA Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -$2.20 B(-9.3%) | -$2.20 B(-6.1%) |
| Sep 2024 | - | -$2.35 B(-1.4%) |
| Jun 2024 | - | -$2.38 B(-1.4%) |
| Mar 2024 | - | -$2.41 B(-0.7%) |
| Dec 2023 | -$2.43 B(+2.6%) | -$2.43 B(-1.8%) |
| Sep 2023 | - | -$2.48 B(+2.7%) |
| Jun 2023 | - | -$2.41 B(-0.0%) |
| Mar 2023 | - | -$2.41 B(+1.8%) |
| Dec 2022 | -$2.37 B(+10.0%) | -$2.37 B(+1.8%) |
| Sep 2022 | - | -$2.33 B(+1.2%) |
| Jun 2022 | - | -$2.30 B(+1.5%) |
| Mar 2022 | - | -$2.27 B(+5.2%) |
| Dec 2021 | -$2.15 B(+8.5%) | -$2.15 B(+2.0%) |
| Sep 2021 | - | -$2.11 B(+0.7%) |
| Jun 2021 | - | -$2.10 B(+2.1%) |
| Mar 2021 | - | -$2.05 B(+3.3%) |
| Dec 2020 | -$1.99 B(+16.5%) | -$1.99 B(+3.5%) |
| Sep 2020 | - | -$1.92 B(+4.6%) |
| Jun 2020 | - | -$1.83 B(+2.4%) |
| Mar 2020 | - | -$1.79 B(+5.2%) |
| Dec 2019 | -$1.70 B(+16.0%) | -$1.70 B(+3.2%) |
| Sep 2019 | - | -$1.65 B(+2.6%) |
| Jun 2019 | - | -$1.61 B(+3.5%) |
| Mar 2019 | - | -$1.55 B(+5.8%) |
| Dec 2018 | -$1.47 B(+20.0%) | -$1.47 B(+4.7%) |
| Sep 2018 | - | -$1.40 B(+4.6%) |
| Jun 2018 | - | -$1.34 B(+5.0%) |
| Mar 2018 | - | -$1.28 B(+4.4%) |
| Dec 2017 | -$1.22 B(+31.0%) | -$1.22 B(+6.0%) |
| Sep 2017 | - | -$1.15 B(+6.0%) |
| Jun 2017 | - | -$1.09 B(+6.6%) |
| Mar 2017 | - | -$1.02 B(+9.4%) |
| Dec 2016 | -$933.98 M(+41.0%) | -$933.98 M(+9.2%) |
| Sep 2016 | - | -$855.28 M(+9.1%) |
| Jun 2016 | - | -$783.67 M(+10.0%) |
| Mar 2016 | - | -$712.35 M(+7.5%) |
| Dec 2015 | -$662.59 M(+33.0%) | -$662.59 M(+7.4%) |
| Sep 2015 | - | -$616.80 M(+6.7%) |
| Jun 2015 | - | -$577.90 M(+7.3%) |
| Mar 2015 | - | -$538.52 M(+8.1%) |
| Dec 2014 | -$498.14 M | -$498.14 M(+6.0%) |
| Sep 2014 | - | -$469.78 M(+5.6%) |
| Jun 2014 | - | -$444.99 M(+5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -$423.50 M(+4.4%) |
| Dec 2013 | -$405.67 M(+10.3%) | -$405.67 M(+3.1%) |
| Sep 2013 | - | -$393.62 M(+2.8%) |
| Jun 2013 | - | -$382.92 M(+2.4%) |
| Mar 2013 | - | -$373.84 M(+1.7%) |
| Dec 2012 | -$367.72 M(+6.0%) | -$367.72 M(+1.9%) |
| Sep 2012 | - | -$360.91 M(+0.7%) |
| Jun 2012 | - | -$358.51 M(+1.5%) |
| Mar 2012 | - | -$353.09 M(+1.8%) |
| Dec 2011 | -$346.87 M(+7.0%) | -$346.87 M(+1.6%) |
| Sep 2011 | - | -$341.57 M(+1.5%) |
| Jun 2011 | - | -$336.50 M(+2.0%) |
| Mar 2011 | - | -$329.94 M(+1.8%) |
| Dec 2010 | -$324.11 M(-4.5%) | -$324.11 M(-8.2%) |
| Sep 2010 | - | -$353.25 M(+1.2%) |
| Jun 2010 | - | -$349.02 M(+1.2%) |
| Mar 2010 | - | -$344.73 M(+1.6%) |
| Dec 2009 | -$339.25 M(+15.4%) | -$339.25 M(+2.6%) |
| Sep 2009 | - | -$330.56 M(+2.7%) |
| Jun 2009 | - | -$321.83 M(+4.1%) |
| Mar 2009 | - | -$309.10 M(+5.1%) |
| Dec 2008 | -$294.10 M(+27.9%) | -$294.10 M(+5.0%) |
| Sep 2008 | - | -$280.14 M(+5.9%) |
| Jun 2008 | - | -$264.52 M(+7.4%) |
| Mar 2008 | - | -$246.24 M(+7.1%) |
| Dec 2007 | -$229.86 M(+32.5%) | -$229.86 M(+8.0%) |
| Sep 2007 | - | -$212.82 M(+8.2%) |
| Jun 2007 | - | -$196.77 M(+5.8%) |
| Mar 2007 | - | -$186.02 M(+7.2%) |
| Dec 2006 | -$173.47 M(+35.1%) | -$173.47 M(+7.7%) |
| Sep 2006 | - | -$161.02 M(+7.5%) |
| Jun 2006 | - | -$149.75 M(+8.6%) |
| Mar 2006 | - | -$137.88 M(+7.4%) |
| Dec 2005 | -$128.42 M(+36.2%) | -$128.42 M(+8.6%) |
| Sep 2005 | - | -$118.22 M(+11.6%) |
| Jun 2005 | - | -$105.91 M(+6.0%) |
| Mar 2005 | - | -$99.87 M(+5.9%) |
| Dec 2004 | -$94.28 M(+37.9%) | -$94.28 M(+8.4%) |
| Sep 2004 | - | -$86.95 M(+7.7%) |
| Jun 2004 | - | -$80.73 M(+7.9%) |
| Mar 2004 | - | -$74.85 M(+9.5%) |
| Dec 2003 | -$68.37 M(+26.0%) | -$68.37 M |
| Dec 2002 | -$54.27 M | - |
FAQ
- What is ACADIA Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?
- What is ACADIA Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?
- What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?
What is ACADIA Pharmaceuticals annual retained earnings?
The current annual retained earnings of ACAD is -$2.20 B
What is the all time high annual retained earnings for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high annual retained earnings is -$54.27 M
What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ACAD annual retained earnings has changed by +$226.45 M (+9.32%)
What is ACADIA Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ACAD is -$2.20 B
What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals all-time high quarterly retained earnings is -$68.37 M
What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ACAD quarterly retained earnings has changed by $0.00 (0.00%)